Ochre Bio Alternatives & Competitors
12 companies similar to Ochre Bio —
Companies similar to Ochre Bio
Yaqrit
The Liver Disease Company
London, United Kingdom
Avidity Biosciences, Inc.
At Avidity, we are developing a new class of oligonucleotide-based therapies.
San Diego, United States
Kernal Biologics
KernalBio creates mRNA therapies that instruct specific cells on how to make their own med...
Cambridge, United States
Lifebit
We built the Federated Trusted Research Environment for the world's most sensitive health...
New York, United States
Rival Readout
Competing with Ochre Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
GLG Pharma
Why Show the GSK Compound? Because the cancer cells become resistant. How? By STAT3! GLG's...
Jupiter, United States
PharmEnable Therapeutics
Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innova...
Cambridge, United Kingdom
Character Biosciences
A patient-driven drug discovery platform for diseases of aging
San Francisco, United Sta...
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...
Boston, United States
KAICO Ltd.
Changing the World with Silkworms
Fukuoka, Japan
Vial
Vial is a next-gen pharma company advancing best-in-class biologics and RNA therapeutics a...
San Francisco, United Sta...
Matchpoint Therapeutics
Acing the future of covalent medicines
About Ochre Bio
Ochre Bio is a dynamic biotechnology company founded in 2019 in the United Kingdom. Specializing in the development of RNA therapies for chronic liver diseases, the company leverages genomic deep phenotyping and precision RNA medicine. Ochre Bio's innovative approach involves testing therapies in live human donor liver...
Development of RNA therapies, AI-driven drug discovery, Human liver data integration, Validation in human liver models
Pharmaceutical companies, Biotech researchers, Medical institutions focusing on liver diseases, Investors in advanced biotech innovations
RNA Therapies, Chronic Liver Diseases, Genomic Deep Phenotyping, Precision Medicine, Transplant Enhancement, Liver Rejuvenation, Genomics, Liver Health, Cirrhosis Complications, Advanced Therapies, Liver Genomics Research, Biotech Innovation
B2B, B2B2B, API
Licensing, Performance Based, Data Monetization
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Ochre Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Ochre Bio on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 21 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
